L. Chaperot

发表

Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells

J. Qin, Yong‐jun Liu, S. Hanabuchi, 2010, Proceedings of the National Academy of Sciences.

[Extracorporeal photochemotherapy or immunotherapy using cells modified by photochemistry].

M. Richard, J. Plumas, L. Chaperot, 2010, La Revue de medecine interne.

Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells

J. Plumas, L. Chaperot, O. Manches, 2003, Leukemia.

Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system.

M. Richard, R. Gressin, M. Favrot, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

Matthias Kretzler, Wenpu Zhao, Laurence Chaperot, 2011, The Journal of Immunology.

Dendritic cells and innate defense against tumor cells.

L. Zitvogel, N. Chaput, J. Plumas, 2008, Cytokine & growth factor reviews.

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

J. Lifson, D. Munn, N. Bhardwaj, 2008, The Journal of clinical investigation.

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs

B. Li, Shigang Yin, S. Xiong, 2017, The Journal of experimental medicine.

T‐cell receptor diversity as a prognostic biomarker in melanoma patients

C. Aspord, F. de Fraipont, J. Plumas, 2020, Pigment cell & melanoma research.

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

R. Gressin, J. Plumas, L. Chaperot, 2001, Blood.

Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.

Marc C. Jacob, J. Plumas, L. Chaperot, 1998, Blood.

Deciphering the Impact of Early-Life Exposures to Highly Variable Environmental Factors on Foetal and Child Health: Design of SEPAGES Couple-Child Cohort

R. Slama, P. Hainaut, V. Siroux, 2019, International journal of environmental research and public health.

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

M. Béné, J. Plumas, L. Chaperot, 2003, Haematologica.

CD 4 + CD 56 + lineage negative maligancies : a new entity developed from malignant early plasmacytoid dendritic cells

M. Béné, L. Chaperot, D. Leroux, 2003 .

Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease

J. Plumas, L. Chaperot, É. Merlin, 2010, Transplantation.

factor for leukemic plasmacytoid dendritic cells Expression of the myeloid-associated marker CD33 is not an exclusive

B. Drénou, F. Garnache-Ottou, E. Deconinck, 2013 .

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.

B. Drénou, F. Garnache-Ottou, J. Rémy-Martin, 2004, Blood.

Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1−)‐pDC subset negatively correlated with clinical outcomes in melanoma patients

C. Aspord, F. de Fraipont, L. Chaperot, 2022, Clinical & translational immunology.

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs

C. Aspord, T. Decaens, D. Durantel, 2020, Clinical & translational immunology.

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

C. Aspord, T. Decaens, D. Durantel, 2019, Front. Immunol..

Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin’s lymphomas

E. Devilard, R. Bouabdallah, F. Birg, 1999, Leukemia.

Tartrate‐Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

I. Bruce, Y. Crow, M. Alarcón‐Riquelme, 2017, Arthritis & rheumatology.

Influenza recombinant vaccine: matrix protein M1 on the platform of the adenovirus dodecahedron.

J. Chroboczek, E. Szołajska, A. Naskalska, 2009, Vaccine.

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

C. Aspord, P. Coulie, B. Dréno, 2020, Oncoimmunology.

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

F. Jardin, J. Picquenot, H. Tilly, 2009, Leukemia.

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.

F. Jardin, E. Brambilla, E. Macintyre, 2016, Blood.

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes

I. Pichová, J. Hodek, I. Hirsch, 2020, Scientific Reports.

Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.

R. Gressin, J. Plumas, L. Chaperot, 1999, Experimental hematology.

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.

F. Bost, J. Plumas, L. Chaperot, 1999, Experimental hematology.

Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells

J. Plumas, L. Chaperot, M. Jacob, 1995, European journal of immunology.

Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases

F. Garnache-Ottou, P. Tiberghien, J. Plumas, 2009, Haematologica.

Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells

C. Aspord, H. Vié, J. Plumas, 2010, Journal of biomedicine & biotechnology.

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

J. Plumas, L. Chaperot, É. Merlin, 2019, Journal of clinical apheresis.

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept

J. Plumas, L. Chaperot, S. Perruche, 2019, Journal of Translational Medicine.

Death receptor 6 is a novel plasmacytoid dendritic cell-specific receptor and modulates type I interferon production

Yong‐jun Liu, J. Plumas, L. Chaperot, 2016, Protein & Cell.

Photochemotherapy Induces the Apoptosis of Monocytes Without Impairing Their Function

J. Plumas, L. Chaperot, O. Hequet, 2010, Transplantation.

TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN.

J. Di Domizio, J. Plumas, L. Chaperot, 2009, Blood.

Innate Sensing of HIV-Infected Cells

M. Si-Tahar, R. Randall, M. Albert, 2011, PLoS pathogens.

This information is current as Lupus Erythematosus Immunostimulatory Molecules in Systemic Damage , Infiltrate Tissues , and Expose Netting Neutrophils Induce Endothelial

J. Hodgin, M. Kretzler, D. Shealy, 2011 .

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells

P. Coulie, B. Dréno, J. Plumas, 2021, Vaccines.

[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells].

C. Aspord, M. Richard, J. Plumas, 2011, La Revue de medecine interne.

Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype

N. Bhardwaj, J. Plumas, L. Chaperot, 2012, Proceedings of the National Academy of Sciences.

A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells

C. Aspord, M. Richard, J. Plumas, 2010, PloS one.

NFATC3 promotes IRF7 transcriptional activity in plasmacytoid dendritic cells

Y. Liu, J. Qin, Yong‐jun Liu, 2016, The Journal of experimental medicine.

Plasmacytoid dendritic cells capture and cross-present viral antigens from influenzavirus exposed cells

J. Plumas, L. Chaperot, O. Manches, 2018 .

Plasmacytoid Dendritic Cells Capture and Cross-Present Viral Antigens from Influenza-Virus Exposed Cells

J. Plumas, L. Chaperot, O. Manches, 2009, PloS one.

Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.

L. Staudt, G. Bhagat, M. Tremblay, 2015, Immunity.

This information is current as Ligase Cbl Signaling by Inhibiting the E 3 Ubiquitin Plasmacytoid Dendritic Cell Receptor CD 2 AP / SHIP 1 Complex Positively Regulates

Yong‐jun Liu, Shao-Cong Sun, W. Cao, 2012 .

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation

J. Davoust, J. Plumas, L. Chaperot, 2009, Journal of Translational Medicine.

Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells1

J. Plumas, L. Chaperot, O. Manches, 2006, The Journal of Immunology.

Preparation of purified lymphoma cells suitable for therapy.

J. Plumas, L. Chaperot, J. Sotto, 2004, Cytotherapy.

The avidity of tumor‐specific T cells amplified by a plasmacytoid dendritic cell‐based assay can predict the clinical evolution of melanoma patients

C. Aspord, J. Plumas, L. Chaperot, 2018, Pigment cell & melanoma research.

Mesenchymal stem cells induce apoptosis of activated T cells

M. Richard, M. Favrot, J. Plumas, 2005, Leukemia.

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c- FLIP short Running title: E2F1 targets c-FLIP S to induce apoptosis

E. Brambilla, B. Eymin, C. Salon, 2020 .

Clinical and biologic features of CD4(+)CD56(+) malignancies.

B. Drénou, M. Béné, R. Gressin, 2002, Blood.

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells

D. Olive, J. Nunès, P. Dubreuil, 2018, Front. Immunol..

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

V. Deneys, S. Lebecque, D. Blanchard, 2004, European journal of immunology.

From the Study of Tumor Cell Immunogenicity to the Generation of Antitumor Cytotoxic Cells in Non-Hodgkin's Lymphomas

J. Plumas, L. Chaperot, M. Jacob, 2000, Leukemia & lymphoma.

Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma

R. Gressin, J. Plumas, L. Chaperot, 1999, Leukemia.

Whole lymphoma B cells allow efficient cross-presentation of antigens by dendritic cells.

J. Plumas, L. Chaperot, J. Sotto, 2008, Cytotherapy.

Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.

B. Lambrecht, G. Schoehn, J. Chroboczek, 2013, Vaccine.

HIV-1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line

R. Gambari, K. Fecchi, M. Sargiacomo, 2021, Viruses.

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells

D. Olive, J. Nunès, S. Létard, 2016, PloS one.

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

C. Aspord, F. Mami-Chouaib, F. Soncin, 2017, Oncoimmunology.

Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomas.

J. Plumas, L. Chaperot, F. Le Vacon, 1997, Leukemia & lymphoma.

Virus overrides the propensity of human CD40L‐activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN‐γ and Th1 chemokine production

G. Trinchieri, C. Caux, J. Plumas, 2005, Journal of leukocyte biology.

Origin and filiation of human plasmacytoid dendritic cells.

G. Trinchieri, J. Plumas, L. Chaperot, 2002, Human immunology.

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

C. Aspord, M. Richard, R. Gressin, 2010, European journal of dermatology : EJD.

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells.

P. Mezin, M. Amacker, A. Grichine, 2007, Vaccine.

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

R. Gressin, J. Plumas, L. Chaperot, 2003, Blood.

Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines

J. Plumas, L. Chaperot, K. Laulagnier, 2023, Genes & cancer.

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort

E. Brambilla, B. Eymin, C. Salon, 2006, Cell Death and Differentiation.

Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells.

J. Plumas, L. Chaperot, D. Plantaz, 2006, Experimental hematology.

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

C. Schwebel, L. Chaperot, N. Sturm, 2019, Experimental Hematology & Oncology.

BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

C. Aspord, F. de Fraipont, L. Chaperot, 2020, Clinical & translational immunology.

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

E. Macintyre, M. Béné, F. Garnache-Ottou, 2009, British journal of haematology.

Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

C. Schaffitzel, B. Verrier, V. Josserand, 2019, Science Advances.

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7

Jianzhu Chen, L. Su, J. Plumas, 2015, The Journal of Immunology.

The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome

C. Aspord, F. de Fraipont, J. Plumas, 2019, Oncoimmunology.

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

J. Plumas, L. Chaperot, F. Garban, 2000, Leukemia.

HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients.

C. Aspord, J. Plumas, L. Chaperot, 2012, The Journal of investigative dermatology.

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications

P. Hainaut, L. Sancey, P. Faure, 2017, BioMed research international.

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients

C. Aspord, F. de Fraipont, L. Landemarre, 2022, Frontiers in Immunology.

Clinical and biologic features of CD 4 1 CD 56 1 malignancies

B. Drénou, M. Béné, R. Gressin, 2002 .

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.

M. Ferrer, L. Staudt, A. Shaffer, 2016, Cancer cell.

The melanoma tumor glyco-code impacts human dendritic cells’ functionality and dictates clinical outcomes

C. Aspord, F. de Fraipont, F. Fieschi, 2023, Frontiers in Immunology.

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes

C. Aspord, F. de Fraipont, L. Chaperot, 2021, Clinical & translational immunology.

Differentiation of anti‐tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non‐Hodgkin's lymphomas

A. Moine, R. Gressin, J. Plumas, 2002, British journal of haematology.

A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients

C. Aspord, E. Brambilla, C. Brambilla, 2023, International journal of molecular sciences.

Induction of Antiviral Cytotoxic T Cells by Plasmacytoid Dendritic Cells for Adoptive Immunotherapy of Posttransplant Diseases

C. Aspord, H. Vié, M. Richard, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

C. Caux, M. Péoc'h, J. Plumas, 2004, Leukemia.

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor.

C. Aspord, J. Di Domizio, J. Plumas, 2010, The Journal of investigative dermatology.

CD2AP/SHIP1 Complex Positively Regulates Plasmacytoid Dendritic Cell Receptor Signaling by Inhibiting the E3 Ubiquitin Ligase Cbl

J. Qin, Shao-Cong Sun, W. Cao, 2012, The Journal of Immunology.

SCARB 2 / LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR 9 and Nuclear Translocation of IRF 7

Xiangyun, Jianzhu Chen, L. Su, 2015 .

Factor 7 Nuclear Translocation of IFN Regulatory Endosomal Translocation of TLR9 and Mediating of Plasmacytoid Dendritic Cells by SCARB2/LIMP-2 Regulates IFN Production

Jianzhu Chen, L. Su, J. Plumas, 2015 .

Impaired Antitumor Immune Response in MYCN-amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment

C. Aspord, H. Sartelet, L. Chaperot, 2022, Cancer research communications.